Virtu Financial’s Wave Life Sciences WVE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
Sell
-76,779
Closed -$557K 2331
2026
Q1
$557K Buy
76,779
+49,890
+186% +$650K 0.02% 529
2025
Q4
$457K Buy
+26,889
New +$273K 0.02% 646
2025
Q1
Sell
-20,819
Closed -$258K 2117
2024
Q4
$258K Buy
+20,819
New +$278K 0.01% 775
2024
Q1
Sell
-34,432
Closed -$174K 2182
2023
Q4
$174K Buy
+34,432
New +$184K 0.01% 883
2022
Q1
Sell
-10,340
Closed -$32K 2100
2021
Q4
$32K Sell
10,340
-2,866
-22% -$11.9K ﹤0.01% 1433
2021
Q3
$65K Buy
+13,206
New +$80.1K 0.01% 1233
2021
Q1
Sell
-14,764
Closed -$116K 2084
2020
Q4
$116K Buy
+14,764
New +$124K 0.01% 1020

Other funds holding WVE

Virtu Financial's WVE Position: Q2 2026 in Review

Virtu Financial sold out of Wave Life Sciences (WVE) in Q2 2026, closing a stake of 76,779 shares — an estimated $557K sold.

Virtu Financial first reported a position in WVE in Q4 2020 and held it in 7 quarters. The position peaked at $557K in Q1 2026. 239 funds tracked by Wall St. Rank hold WVE as of Q2 2026.

  • Virtu Financial reported no remaining Wave Life Sciences position as of Q2 2026 after selling out during the quarter.
  • Virtu Financial sold 76,779 Wave Life Sciences shares in Q2 2026, an estimated $557K.
  • Virtu Financial first reported a position in Wave Life Sciences in Q4 2020 and held it in 7 quarters.
  • Virtu Financial's Wave Life Sciences position peaked at $557K in Q1 2026.
  • 239 funds tracked by Wall St. Rank held Wave Life Sciences as of Q2 2026.

Based on Virtu Financial's 13F filing for Q2 2026, filed 13 Aug 2026.